Good Manufacturing Practice Production of Adenoviral Vectors for Clinical Trials
- 1 March 2005
- journal article
- review article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 16 (3) , 281-291
- https://doi.org/10.1089/hum.2005.16.281
Abstract
The increasing importance of recombinant adenoviral vectors for gene therapy, cancer therapy, and the development of prophylactic and therapeutic vaccines has led to worldwide efforts toward scalable process development suitable for commercial manufacturing of replication-deficient adenoviral vectors. This review focuses on the manufacturing of adenovirus for clinical trials in the context of good manufacturing practice conditions and regulations.Keywords
This publication has 41 references indexed in Scilit:
- Adenovirus Vector-Based Vaccines for Human Immunodeficiency Virus Type 1Human Gene Therapy, 2005
- Adenovirus-Based Genetic Vaccines for BiodefenseHuman Gene Therapy, 2005
- High-Titer Adenovirus Vector Production in 293S Cell Perfusion CultureBiotechnology Progress, 2004
- Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectorsBiotechnology & Bioengineering, 2004
- Large‐scale propagation of a replication‐defective adenovirus vector in stirred‐tank bioreactor PER.C6™ cell culture under sparging conditionsBiotechnology & Bioengineering, 2003
- Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agentsCancer Cell, 2002
- A Single Short Stretch of Homology Between Adenoviral Vector and Packaging Cell Line Can Give Rise to Cytopathic Effect-Inducing, Helper-Dependent E1-Positive ParticlesHuman Gene Therapy, 2002
- Trans-Complementation of E1-Deleted Adenovirus: A New Vector to Reduce the Possibility of Codissemination of Wild-Type and Recombinant AdenovirusesHuman Gene Therapy, 1995
- Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 CellsHuman Gene Therapy, 1994
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977